AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?
The pharmaceutical market is currently defined by a race to replace aging blockbusters with next-generation therapies. Deciding whether…
Eli Lilly CEO still wants deal to bring Mounjaro to Australia under PBS
Eli Lilly pharmaceuticals CEO David Ricks says he still wants to reach an agreement with the Australian government…
Semaglutide Generics Surge in Sales Despite Supply Challenges, ETPharma
New Delhi: After a brief slowdown, sales of generic versions of the weight-loss drug semaglutide recorded a strong…
Will Mounjaro & Zepbound Drive Lilly’s Q2 Results: Buy, Sell or Hold?
Eli Lilly and Company LLY will report its second-quarter 2026 earnings on Aug. 5, before market open. The Zacks…
‘Super weight loss’ drug retatrutide could be available soon
KENT COUNTY, Mich — A new weight loss drug could soon be joining the growing list of medications…
Lilly to file for next-gen obesity drug approval in early 2027
Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
Does EU Approval of Wegovy Pill Change NVO’s Competitive Story?
Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of…
Teens Are Injecting Retatrutide, an Unapproved Weight-Loss Peptide Viral on TikTok
Greta sits in her car and sings to the camera: “Greta, reta, bo, beta, banana, fana, fo, feta,…
Teens Are Injecting Retatrutide, an Unapproved Weight-Loss Peptide Viral on TikTok
Greta sits in her car and sings to the camera: “Greta, reta, bo, beta, banana, fana, fo, feta,…
Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years?
The short, but glib, answer to the headline question posed for Viking Therapeutics (NASDAQ: VKTX) investors is “no,”…